TXMD vs. CORT
Compare and contrast key facts about TherapeuticsMD, Inc. (TXMD) and Corcept Therapeutics Incorporated (CORT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: TXMD or CORT.
Correlation
The correlation between TXMD and CORT is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
TXMD vs. CORT - Performance Comparison
Key characteristics
TXMD:
-0.28
CORT:
1.50
TXMD:
0.30
CORT:
4.18
TXMD:
1.04
CORT:
1.57
TXMD:
-0.29
CORT:
4.35
TXMD:
-0.74
CORT:
12.52
TXMD:
38.83%
CORT:
15.79%
TXMD:
110.51%
CORT:
122.13%
TXMD:
-99.99%
CORT:
-94.28%
TXMD:
-99.98%
CORT:
-37.51%
Fundamentals
TXMD:
$16.44M
CORT:
$7.72B
TXMD:
-$0.20
CORT:
$1.23
TXMD:
-0.73
CORT:
0.61
TXMD:
9.37
CORT:
11.62
TXMD:
0.60
CORT:
11.36
TXMD:
$2.12M
CORT:
$685.45M
TXMD:
$2.12M
CORT:
$674.70M
TXMD:
-$3.29M
CORT:
$111.33M
Returns By Period
In the year-to-date period, TXMD achieves a 62.79% return, which is significantly higher than CORT's 41.66% return. Over the past 10 years, TXMD has underperformed CORT with an annualized return of -41.66%, while CORT has yielded a comparatively higher 28.81% annualized return.
TXMD
62.79%
59.09%
-7.89%
-31.03%
-53.48%
-41.66%
CORT
41.66%
1.26%
31.45%
181.02%
39.82%
28.81%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
TXMD vs. CORT — Risk-Adjusted Performance Rank
TXMD
CORT
TXMD vs. CORT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for TherapeuticsMD, Inc. (TXMD) and Corcept Therapeutics Incorporated (CORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
TXMD vs. CORT - Dividend Comparison
Neither TXMD nor CORT has paid dividends to shareholders.
Drawdowns
TXMD vs. CORT - Drawdown Comparison
The maximum TXMD drawdown since its inception was -99.99%, which is greater than CORT's maximum drawdown of -94.28%. Use the drawdown chart below to compare losses from any high point for TXMD and CORT. For additional features, visit the drawdowns tool.
Volatility
TXMD vs. CORT - Volatility Comparison
TherapeuticsMD, Inc. (TXMD) has a higher volatility of 21.24% compared to Corcept Therapeutics Incorporated (CORT) at 16.59%. This indicates that TXMD's price experiences larger fluctuations and is considered to be riskier than CORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
TXMD vs. CORT - Financials Comparison
This section allows you to compare key financial metrics between TherapeuticsMD, Inc. and Corcept Therapeutics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TXMD vs. CORT - Profitability Comparison
TXMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, TherapeuticsMD, Inc. reported a gross profit of 667.00K and revenue of 667.00K. Therefore, the gross margin over that period was 100.0%.
CORT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Corcept Therapeutics Incorporated reported a gross profit of 154.81M and revenue of 157.21M. Therefore, the gross margin over that period was 98.5%.
TXMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, TherapeuticsMD, Inc. reported an operating income of -319.00K and revenue of 667.00K, resulting in an operating margin of -47.8%.
CORT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Corcept Therapeutics Incorporated reported an operating income of 3.42M and revenue of 157.21M, resulting in an operating margin of 2.2%.
TXMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, TherapeuticsMD, Inc. reported a net income of 252.00K and revenue of 667.00K, resulting in a net margin of 37.8%.
CORT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Corcept Therapeutics Incorporated reported a net income of 20.29M and revenue of 157.21M, resulting in a net margin of 12.9%.